Role of minimally invasive surgery in ovarian cancer

Journal of Minimally Invasive Gynecology

Volumn 20, Issue 6, 2013, Pages 754-765

  Nezhat, Farr R ^a   Pejovic, Tanja ^b   Finger, Tamara N ^a   Khalil, Susan S ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cytoreduction; Laparoscopy; Ovarian cancer; Robotic assisted laparoscopy; Staging

Indexed keywords

CA 125 ANTIGEN;

ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER REGRESSION; CANCER STAGING; CYTOREDUCTIVE SURGERY; ENDOMETRIUM CANCER; HAND ASSISTED LAPAROSCOPY; HUMAN; HYSTERECTOMY; LAPAROSCOPIC SURGERY; LAPAROSCOPY; LAPAROTOMY; MINIMALLY INVASIVE SURGERY; OVARY CANCER; OVARY CARCINOMA; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; RECURRENT CANCER; REVIEW; ROBOTIC ASSISTED LAPAROSCOPY; ROBOTICS; SALPINGOOOPHORECTOMY; SECOND LOOK SURGERY; TELESURGERY; UTERINE CERVIX CANCER;

CYTOREDUCTION; LAPAROSCOPY; OVARIAN CANCER; ROBOTIC-ASSISTED LAPAROSCOPY; STAGING;

FEMALE; HUMANS; HYSTERECTOMY; LAPAROSCOPY; OVARIAN NEOPLASMS; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 84886848547     PISSN: 15534650     EISSN: 15534669     Source Type: Journal    
DOI: 10.1016/j.jmig.2013.04.027     Document Type: Review

References (40)

1. American Cancer Society Cancer Facts and Figures, 2011 2011, American Cancer Society, Atlanta, GA.
2. Pearce C.L., Templeman C., Rossing M.A., et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol 2012, 13:385-394. Ovarian Cancer Association Consortium.
3. Deligdisch L., Penault-Llorca F., Schlosshauer P., Altchek A., Peiretti M., Nezhat F. Stage I ovarian carcinoma: different clinical pathologic patterns. Fertil Steril 2007, 88:906-910.
4. Jemal A., Siegel R., Xu J., Ward E. Cancer Statistics, 2010 [published correction appears in CA Cancer J Clin. 2011;61:133-134]. CA Cancer J Clin 2010, 60:277-300.
5. Crum C.P., McKeon F.D., Xian W. BRCA, the oviduct, and the space and time continuum of pelvic serous carcinogenesis. Int J Gynecol Cancer 2012, 22:S29-S34.
6. Katz V.L., Lentz G.M., Lobo R.A., Gershenson D.M. Comprehensive Gynecology 2007, Mosby Elsevier, Philadelphia, PA. 5th ed.
7. Querleu D., Leblanc E. Laparoscopic infrarenal para-aortic lymph node dissection for restaging of carcinoma of the ovary or fallopian tube. Cancer 1994, 73:1467-1471.
8. Amara D.P., Nezhat C., Teng N., Nezhat F., Nezhat C., Rosati M. Operative laparoscopy in the management of ovarian cancer. Surg Laparosc Endosc 1996, 6:38-45.
9. Liu C.S., Nagarsheth N.P., Nezhat F.R. Laparoscopy and ovarian cancer: a paradigm change in the management of ovarian cancer?. J Minim Invasive Gynecol 2009, 16:250-262.
10. Stier E.A., Barakat R.R., Curtin J.P., Brown C.L., Jones W.B., Hoskins W.J. Laparotomy to complete staging of presumed early ovarian cancer. Obstet Gynecol 1996, 87:737-740.
11. Childers J.M., Lang J., Surwit E.A., Hatch K.D. Laparoscopic surgical staging of ovarian cancer. Gynecol Oncol 1995, 59:25-33.
12. Angioli R., Muzii L., Battista C., et al. The role of laparoscopy in ovarian carcinoma. Minerva Gynecol 2009, 61:35-43.
13. Tozzi R., Schneider A. Laparoscopic treatment of early ovarian cancer. Curr Opin Obstet Gynecol 2005, 17:354-358.
14. Weber S., McCann C.K., Boruta D.M., Schorge J.O., Growdon W.B. Laparoscopic surgical staging of early ovarian cancer. Rev Obstet Gynecol 2011, 4:117-122.
15. Nezhat F.R., Ezzati M., Chuang L., et al. Laparoscopic management of early ovarian and fallopian tube cancers: surgical and survival outcome. Am J Obstet Gynecol 2009, 200:83-85.
16. Sternchos J., Finger T., Mahdavi A., Nezhat F. Laparoscopic management of ovarian, fallopian tube and primary peritoneal cancer. Nezhat's Video-Assisted and Robotic-Assisted Laparoscopy and Hysteroscopy 2013, 508-525. Cambridge University Press, Cambridge, MA. 4th ed. C. Nezhat, F. Nezhat, C. Nezhat (Eds.).
17. Nezhat F.R., DeNoble S.M., Liu C.S., et al. The safety and efficacy of laparoscopic surgical staging and debulking of apparent advanced stage ovarian, fallopian tube, and primary peritoneal cancers. JSLS 2010, 14:155-168.
18. Fanning J., Yacoub E., Hojat R. Laparoscopic-assisted cytoreduction for primary ovarian cancer: success, morbidity and survival. Gynecol Oncol 2011, 123:47-49.
19. Krivak T.C., Elkas J.C., Rose G.S., et al. The utility of hand-assisted laparoscopy in ovarian cancer. Gynecol Oncol 2005, 96:72-76.
20. Magrina J.F., Zanagnolo V., Noble B.N., Kho R.M., Magtibay P. Robotic approach for ovarian cancer: perioperative and survival results and comparison with laparoscopy and laparotomy. Gynecol Oncol 2011, 121:100-105.
21. Bristow R.E., Tomacruz S.R., Armstrong D.K., Trimble E.L., Montz F.J. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta analysis. J Clin Oncol 2002, 20:1248-1259.
22. Winter W.E., Maxwell G.L., Tian C., et al. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol 2007, 25:3621-3627. Gynecologic Oncology Group Study.
23. Winter W.E., Maxwell G.L., Tian C., et al. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol 2008, 26:83-89. Gynecologic Oncology Group.
24. Du Bois A., Reuss A., Pujade-Lauraine E., Harter P., Ray-Coguard I., Pfisterer J. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials; by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d' Investigateurs Nationaux pour les Etudes des Cancers l'Ovaire (GINECO). Cancer 2009, 115:1234-1244.
25. Vergote I., Tropé C.G., Amant F., et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med 2010, 363:943-953. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Group; NCIC Clinical Trials Group.
26. Nezhat F., Olfer L. The Role of Minimally Invasive Surgery in Ovarian Cancer [letter to editor]. Int J Gyencol Cancer 2013, 23:782-783.
27. Gemer O., Gdalevich M., Ravid M., et al. A multicenter validation of computerized tomography models as predictors of non-optimal primary cytoreduction of advanced epithelial ovarian cancer. Eur J Surg Oncol 2009, 35:1109-1112.
28. Gemer O., Lurian M., Gdalevich M., et al. A multicenter study of CA 125 level as a predictor of non-optimal primary cytoreduction of advanced epithelial ovarian cancer. Eur J Surg Oncol 2005, 31:1006-1010.
29. Kang S., Park S.Y. To predict or not to predict? the dilemma of predicting the risk of suboptimal cytoreduction in ovarian cancer. Ann Oncol 2011, 22(Suppl 8):viii23-viii28.
30. Fagotti A., Ferrandina G., Fanfani F., et al. A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study. Ann Surg Oncol 2006, 13:1156-1161.
31. Rutten M.J., Gaarenstroom K.N., Van Gorp T., et al. Laparoscopy to predict the result of primary cytoreductive surgery in advanced ovarian cancer patients (LapOvCa-trial): a multicentre randomized controlled study. BMC Cancer 2012, 12:31.
32. Abu-Rustum N.R., Barakat R.R., Siegel P.L., Venkatraman E., Curtin J.P., Hoskins W.J. Second-look operation for epithelial ovarian cancer: laparoscopy or laparotomy?. Obstet Gynecol 1996, 88:549-553.
33. Schorge J.O., Wingo S.N., Bhore R., Heffernan T.P., Lea J.S. Secondary cytoreductive surgery for recurrent platinum-sensitive ovarian cancer. Int J Gynaecol Obstet 2010, 108:123-127.
34. Frederick P.J., McQuinn L., Milam M.R., et al. Preoperative factors predicting survival after secondary cytoreduction for recurrent ovarian cancer. Int J Gynecol Cancer 2011, 21:831-836.
35. Chi D.S., Abu-Rustum N.R., Sonoda Y., et al. Laparoscopic and hand-assisted laparoscopic splenectomy for recurrent and persistent ovarian cancer. Gynecol Oncol 2006, 101:224-227.
36. Trinh H., Ott C., Fanning J. Feasibility of laparoscopic debulking with electrosurgical loop excision procedure and argon beam coagulator at recurrence in patients with previous laparotomy debulking. Am J Obstet Gynecol 2004, 190:1394-1397.
37. Nezhat F.R., Denoble S.M., Cho J.E., et al. The safety and efficacy of video laparoscopic surgical debulking of recurrent ovarian, fallopian tube, and primary peritoneal cancers. JSLS 2012, 16:511-518.
38. Holloway R.W., Brudie L.A., Rakowski J.A., Ahmad S. Robotic-assisted resection of liver and diaphragm recurrent ovarian carcinoma: description of technique. Gynecol Oncol 2011, 120:419-422.
39. Ramirez P.T., Adams S., Boggess J.F., et al. Robotic-assisted surgery in gynecologic oncology: a Society of Gynecologic Oncology consensus statement. Developed by the Society of Gynecologic Oncology's Clinical Practice Robotics Task Force. Gynecol Oncol 2012, 124:180-184.
40. Nezhat F, Khalil S, Finger T. Combined conventional and robotic-assisted laparoscopy for staging and debulking of early, advanced and recurrent ovarian, fallopian tube and primary peritoneal cancer: a hybrid technique. Submitted.